Alan Huang is Chief Scientific Officer of Tango Therapeutics, Inc.. Currently has a direct ownership of 167,584 shares of TNGX, which is worth approximately $522,862. The most recent transaction as insider was on Mar 01, 2023, when has been sold 31,697 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
0% 3M change
0% 12M change
Total Value Held $522,862

Alan Huang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2023
BUY
Grant, award, or other acquisition
-
31,697 Added 15.91%
167,584 Common Stock
AH

Alan Huang

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on TNGX

Follow Tango Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

News

Receive news related to Tango Therapeutics, Inc.

Track Activities on TNGX